世界のPD-1＆PD-L1モノクローナル抗体市場予測（～2028年）：PD-1、 PD-L1

• 英文タイトル：Global PD-1 and PD-L1 Monoclonal Antibody Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8927 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

PD-1＆PD-L1モノクローナル抗体市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のPD-1＆PD-L1モノクローナル抗体の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 PD-1＆PD-L1モノクローナル抗体市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・PD-1、 PD-L1 用途別セグメントは次のように区分されます。 ・肺がん、肝臓がん、食道がん、胃がん、鼻咽頭がん、頭頸部がん、その他 世界のPD-1＆PD-L1モノクローナル抗体市場の主要な市場プレーヤーは以下のとおりです。 ・Merk、Bristol-Myers Squibb Company、Roche、Pfizer、AstraZeneca、Junshi Biosciences、Innovent、Hengrui、BeiGene、Alphamab Oncology、Cstone、Akeso 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、PD-1＆PD-L1モノクローナル抗体製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なPD-1＆PD-L1モノクローナル抗体メーカーの企業概要、2019年～2022年までのPD-1＆PD-L1モノクローナル抗体の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なPD-1＆PD-L1モノクローナル抗体メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別PD-1＆PD-L1モノクローナル抗体の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのPD-1＆PD-L1モノクローナル抗体の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのPD-1＆PD-L1モノクローナル抗体市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびPD-1＆PD-L1モノクローナル抗体の産業チェーンを掲載しています。 ・第13、14、15章では、PD-1＆PD-L1モノクローナル抗体の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Merk、Bristol-Myers Squibb Company、Roche、Pfizer、AstraZeneca、Junshi Biosciences、Innovent、Hengrui、BeiGene、Alphamab Oncology、Cstone、Akeso ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：PD-1、 PD-L1 ・用途別分析2017年-2028年：肺がん、肝臓がん、食道がん、胃がん、鼻咽頭がん、頭頸部がん、その他 ・PD-1＆PD-L1モノクローナル抗体の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・PD-1＆PD-L1モノクローナル抗体のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・PD-1＆PD-L1モノクローナル抗体のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・PD-1＆PD-L1モノクローナル抗体の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・PD-1＆PD-L1モノクローナル抗体の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The PD-1 and PD-L1 Monoclonal Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global PD-1 and PD-L1 Monoclonal Antibody market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Lung Cancer accounting for % of the PD-1 and PD-L1 Monoclonal Antibody global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While PD-1 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of PD-1 and PD-L1 Monoclonal Antibody include Merk, Bristol-Myers Squibb Company, Roche, Pfizer, and AstraZeneca, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
PD-1 and PD-L1 Monoclonal Antibody market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
PD-1
PD-L1
Market segment by Application can be divided into
Lung Cancer
Liver Cancer
Esophageal Cancer
Gastric Cancer
Nasopharyngeal Carcinoma
Head and Neck Cancer
Other
The key market players for global PD-1 and PD-L1 Monoclonal Antibody market are listed below:
Merk
Bristol-Myers Squibb Company
Roche
Pfizer
AstraZeneca
Junshi Biosciences
Innovent
Hengrui
BeiGene
Alphamab Oncology
Cstone
Akeso
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PD-1 and PD-L1 Monoclonal Antibody product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of PD-1 and PD-L1 Monoclonal Antibody, with price, sales, revenue and global market share of PD-1 and PD-L1 Monoclonal Antibody from 2019 to 2022.
Chapter 3, the PD-1 and PD-L1 Monoclonal Antibody competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PD-1 and PD-L1 Monoclonal Antibody breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and PD-1 and PD-L1 Monoclonal Antibody market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of PD-1 and PD-L1 Monoclonal Antibody.
Chapter 13, 14, and 15, to describe PD-1 and PD-L1 Monoclonal Antibody sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 PD-1 and PD-L1 Monoclonal Antibody Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 PD-1
1.2.3 PD-L1
1.3 Market Analysis by Application
1.3.1 Overview: Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Lung Cancer
1.3.3 Liver Cancer
1.3.4 Esophageal Cancer
1.3.5 Gastric Cancer
1.3.6 Nasopharyngeal Carcinoma
1.3.7 Head and Neck Cancer
1.3.8 Other
1.4 Global PD-1 and PD-L1 Monoclonal Antibody Market Size & Forecast
1.4.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales in Value (2017 & 2021 & 2028)
1.4.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales in Volume (2017-2028)
1.4.3 Global PD-1 and PD-L1 Monoclonal Antibody Price (2017-2028)
1.5 Global PD-1 and PD-L1 Monoclonal Antibody Production Capacity Analysis
1.5.1 Global PD-1 and PD-L1 Monoclonal Antibody Total Production Capacity (2017-2028)
1.5.2 Global PD-1 and PD-L1 Monoclonal Antibody Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 PD-1 and PD-L1 Monoclonal Antibody Market Drivers
1.6.2 PD-1 and PD-L1 Monoclonal Antibody Market Restraints
1.6.3 PD-1 and PD-L1 Monoclonal Antibody Trends Analysis
2 Manufacturers Profiles
2.1 Merk
2.1.1 Merk Details
2.1.2 Merk Major Business
2.1.3 Merk PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.1.4 Merk PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bristol-Myers Squibb Company
2.2.1 Bristol-Myers Squibb Company Details
2.2.2 Bristol-Myers Squibb Company Major Business
2.2.3 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.2.4 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.3.4 Roche PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.4.4 Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.5.4 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Junshi Biosciences
2.6.1 Junshi Biosciences Details
2.6.2 Junshi Biosciences Major Business
2.6.3 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.6.4 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Innovent
2.7.1 Innovent Details
2.7.2 Innovent Major Business
2.7.3 Innovent PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.7.4 Innovent PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Hengrui
2.8.1 Hengrui Details
2.8.2 Hengrui Major Business
2.8.3 Hengrui PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.8.4 Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 BeiGene
2.9.1 BeiGene Details
2.9.2 BeiGene Major Business
2.9.3 BeiGene PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.9.4 BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Alphamab Oncology
2.10.1 Alphamab Oncology Details
2.10.2 Alphamab Oncology Major Business
2.10.3 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.10.4 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Cstone
2.11.1 Cstone Details
2.11.2 Cstone Major Business
2.11.3 Cstone PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.11.4 Cstone PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Akeso
2.12.1 Akeso Details
2.12.2 Akeso Major Business
2.12.3 Akeso PD-1 and PD-L1 Monoclonal Antibody Product and Services
2.12.4 Akeso PD-1 and PD-L1 Monoclonal Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 PD-1 and PD-L1 Monoclonal Antibody Breakdown Data by Manufacturer
3.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in PD-1 and PD-L1 Monoclonal Antibody
3.4 Market Concentration Rate
3.4.1 Top 3 PD-1 and PD-L1 Monoclonal Antibody Manufacturer Market Share in 2021
3.4.2 Top 6 PD-1 and PD-L1 Monoclonal Antibody Manufacturer Market Share in 2021
3.5 Global PD-1 and PD-L1 Monoclonal Antibody Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and PD-1 and PD-L1 Monoclonal Antibody Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Size by Region
4.1.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Region (2017-2028)
4.1.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2017-2028)
4.2 North America PD-1 and PD-L1 Monoclonal Antibody Revenue (2017-2028)
4.3 Europe PD-1 and PD-L1 Monoclonal Antibody Revenue (2017-2028)
4.4 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue (2017-2028)
4.5 South America PD-1 and PD-L1 Monoclonal Antibody Revenue (2017-2028)
4.6 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Revenue (2017-2028)
5 Market Segment by Type
5.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Type (2017-2028)
5.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Type (2017-2028)
5.3 Global PD-1 and PD-L1 Monoclonal Antibody Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Application (2017-2028)
6.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Application (2017-2028)
6.3 Global PD-1 and PD-L1 Monoclonal Antibody Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2028)
7.2 North America PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2028)
7.3 North America PD-1 and PD-L1 Monoclonal Antibody Market Size by Country
7.3.1 North America PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Country (2017-2028)
7.3.2 North America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2028)
8.2 Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2028)
8.3 Europe PD-1 and PD-L1 Monoclonal Antibody Market Size by Country
8.3.1 Europe PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Country (2017-2028)
8.3.2 Europe PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2028)
9.2 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2028)
9.3 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Market Size by Region
9.3.1 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2028)
10.2 South America PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2028)
10.3 South America PD-1 and PD-L1 Monoclonal Antibody Market Size by Country
10.3.1 South America PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Country (2017-2028)
10.3.2 South America PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2028)
11.2 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2028)
11.3 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Market Size by Country
11.3.1 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of PD-1 and PD-L1 Monoclonal Antibody and Key Manufacturers
12.2 Manufacturing Costs Percentage of PD-1 and PD-L1 Monoclonal Antibody
12.3 PD-1 and PD-L1 Monoclonal Antibody Production Process
12.4 PD-1 and PD-L1 Monoclonal Antibody Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 PD-1 and PD-L1 Monoclonal Antibody Typical Distributors
13.3 PD-1 and PD-L1 Monoclonal Antibody Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---